293 related articles for article (PubMed ID: 27841789)
1. Development of the respiratory tract microbiota in cystic fibrosis.
de Koff EM; Groot KM; Bogaert D
Curr Opin Pulm Med; 2016 Nov; 22(6):623-628. PubMed ID: 27841789
[TBL] [Abstract][Full Text] [Related]
2. Development of the respiratory tract microbiota in cystic fibrosis.
de Koff EM; de Winter – de Groot KM; Bogaert D
Curr Opin Pulm Med; 2016 Nov; 22(6):623-8. PubMed ID: 27583669
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
[TBL] [Abstract][Full Text] [Related]
4. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
[TBL] [Abstract][Full Text] [Related]
5. The cystic fibrosis lung microbiome.
Surette MG
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.
Caverly LJ; Zhao J; LiPuma JJ
Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S31-8. PubMed ID: 26335953
[TBL] [Abstract][Full Text] [Related]
7. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Green H; Jones AM
Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
[TBL] [Abstract][Full Text] [Related]
8. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
Aanæs K
J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.
Caverly LJ; LiPuma JJ
Expert Rev Respir Med; 2018 Oct; 12(10):857-865. PubMed ID: 30118374
[TBL] [Abstract][Full Text] [Related]
10. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
[TBL] [Abstract][Full Text] [Related]
11. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
12. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
[TBL] [Abstract][Full Text] [Related]
13. Help, hinder, hide and harm: what can we learn from the interactions between
Limoli DH; Hoffman LR
Thorax; 2019 Jul; 74(7):684-692. PubMed ID: 30777898
[TBL] [Abstract][Full Text] [Related]
14. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
[TBL] [Abstract][Full Text] [Related]
15. Cystic Fibrosis: Microbiology and Host Response.
Zemanick ET; Hoffman LR
Pediatr Clin North Am; 2016 Aug; 63(4):617-36. PubMed ID: 27469179
[TBL] [Abstract][Full Text] [Related]
16. The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
Frayman KB; Armstrong DS; Carzino R; Ferkol TW; Grimwood K; Storch GA; Teo SM; Wylie KM; Ranganathan SC
Thorax; 2017 Dec; 72(12):1104-1112. PubMed ID: 28280235
[TBL] [Abstract][Full Text] [Related]
17. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.
Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ
ISME J; 2016 May; 10(5):1081-91. PubMed ID: 26555248
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis could be one of the anti-cheating mechanisms for Pseudomonas aeruginosa society.
Huang Z; Jiang Y; Liang J
Med Hypotheses; 2011 Feb; 76(2):166-8. PubMed ID: 20934258
[TBL] [Abstract][Full Text] [Related]
19. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
20. Emerging cystic fibrosis pathogens and the microbiome.
Mahenthiralingam E
Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():13-5. PubMed ID: 24832700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
